Diane C. Young is SVP, CHIEF MEDICAL OFFICER of Celldex Therapeutics, Inc.. Currently has a direct ownership of 17,115 shares of CLDX, which is worth approximately $434,549. The most recent transaction as insider was on Jun 11, 2024, when has been sold 15,000 shares (Common Stock) at a price of $2.71 per share, resulting in proceeds of $40,650. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.1K
0% 3M change
709.22% 12M change
Total Value Held $434,549

Diane C. Young Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2024
BUY
Exercise of conversion of derivative security
$40,650 $2.71 p/Share
15,000 Added 46.71%
17,115 Common Stock
Jun 07 2024
SELL
Open market or private sale
$1,586,700 $35.26 p/Share
45,000 Reduced 95.51%
2,115 Common Stock
Aug 17 2022
SELL
Open market or private sale
$708,700 $37.3 p/Share
19,000 Reduced 89.98%
2,115 Common Stock
Aug 17 2022
BUY
Exercise of conversion of derivative security
$419,200 $6.55 p/Share
64,000 Added 57.6%
47,115 Common Stock
Nov 12 2021
SELL
Open market or private sale
$197,524 $42.94 p/Share
4,600 Reduced 68.5%
2,115 Common Stock
Nov 12 2021
BUY
Exercise of conversion of derivative security
$47,748 $10.38 p/Share
4,600 Added 40.65%
6,715 Common Stock
DCY

Diane C. Young

SVP, CHIEF MEDICAL OFFICER
Hampton, NJ

Track Institutional and Insider Activities on CLDX

Follow Celldex Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLDX shares.

Notify only if

Insider Trading

Get notified when an Celldex Therapeutics, Inc. insider buys or sells CLDX shares.

Notify only if

News

Receive news related to Celldex Therapeutics, Inc.

Track Activities on CLDX